NEWS
Find a Professional: Explore Experts Across 197 Disciplines in 221 Countries!
Just Updated: Compare Your Institution (Live Data)
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025 (Updated Today)
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
Login
Register & Pricing
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
For Students
local_fire_department
Country Reports
person
Find a Professional
Shiu-Chung Au
Tufts Medical Center - Boston / United States
Medical and Health Sciences / Dermatology and Venereology
AD Scientific Index ID: 4620170
Registration, Add Profile,
Premium Membership
Get Your Global Impact Certificate
Ranking &
Analysis
Job
Experiences
Education
Information
Published Books
Book Chapters
Articles
Presentations
Lessons
Projects
Co-Authors
Subject Leaders
Editorship, Referee &
Scientific Board
Patents /
Designs
Academic Grants
& Awards
Artistic
Activities
Certificate / Course
/ Trainings
Association &
Society Memberships
Contact, Office
& Social Media
person_outline
Shiu-Chung Au's MOST POPULAR ARTICLES
1-)
NF-κB: an essential transcription factor in psoriasisAM Goldminz, SC Au, N Kim, AB Gottlieb, PF LizzulJournal of dermatological science 69 (2), 89-94, 20132442013
2-)
Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinibB Rothstein, D Joshipura, A Saraiya, R Abdat, H Ashkar, Y Turkowski, ...Journal of the American Academy of Dermatology 76 (6), 1054-1060. e1, 20171612017
3-)
A phase 2, open-label, investigator-initiated study to evaluate the safety and efficacy of apremilast in subjects with recalcitrant allergic contact or atopic dermatitis.EM Volf, SC Au, N Dumont, P Scheinman, AB GottliebJournal of drugs in dermatology: JDD 11 (3), 341-346, 2012912012
4-)
Etanercept: efficacy and safety for approved indicationsTA Kerensky, AB Gottlieb, S Yaniv, S AuExpert opinion on drug safety 11 (1), 121-139, 2012982012
5-)
A Comparison of Psoriasis Drug Failure Rates and Reasons for Discontinuation in Biologics vs Conventional Systemic Therapies.AA Levin, AB Gottlieb, SC AuJournal of drugs in dermatology: JDD 13 (7), 848-853, 2014942014
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept